160 related articles for article (PubMed ID: 21958870)
1. C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells.
Brognara E; Lampronti I; Breveglieri G; Accetta A; Corradini R; Manicardi A; Borgatti M; Canella A; Multineddu C; Marchelli R; Gambari R
Eur J Pharmacol; 2011 Dec; 672(1-3):30-7. PubMed ID: 21958870
[TBL] [Abstract][Full Text] [Related]
2. New uracil dimers showing erythroid differentiation inducing activities.
Accetta A; Corradini R; Sforza S; Tedeschi T; Brognara E; Borgatti M; Gambari R; Marchelli R
J Med Chem; 2009 Jan; 52(1):87-94. PubMed ID: 19072686
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of gamma-globin mRNA and induction of irreversible erythroid differentiation after treatment of CML cell line K562 with new doxorubicin derivatives.
Szulawska A; Arkusinska J; Czyz M
Biochem Pharmacol; 2007 Jan; 73(2):175-84. PubMed ID: 17097070
[TBL] [Abstract][Full Text] [Related]
4. Erythroid induction of chronic myelogenous leukemia K562 cells following treatment with a photoproduct derived from the UV-A irradiation of 5-methoxypsoralen.
Salvador A; Dall'Acqua S; Sardo MS; Caffieri S; Vedaldi D; Dall'Acqua F; Borgatti M; Zuccato C; Bianchi N; Gambari R
ChemMedChem; 2010 Sep; 5(9):1506-12. PubMed ID: 20645383
[TBL] [Abstract][Full Text] [Related]
5. Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation.
Lee YL; Chen CW; Liu FH; Huang YW; Huang HM
PLoS One; 2013; 8(4):e61939. PubMed ID: 23613979
[TBL] [Abstract][Full Text] [Related]
6. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
Huang HM; Liu JC
J Cell Physiol; 2009 Mar; 218(3):568-74. PubMed ID: 19006173
[TBL] [Abstract][Full Text] [Related]
7. Plastrum testudinis induces γ-globin gene expression through epigenetic histone modifications within the γ-globin gene promoter via activation of the p38 MAPK signaling pathway.
Qian X; Chen J; Zhao D; Guo L; Qian X
Int J Mol Med; 2013 Jun; 31(6):1418-28. PubMed ID: 23588991
[TBL] [Abstract][Full Text] [Related]
8. Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs.
Lampronti I; Bianchi N; Zuccato C; Dall'Acqua F; Vedaldi D; Viola G; Potenza R; Chiavilli F; Breveglieri G; Borgatti M; Finotti A; Feriotto G; Salvatori F; Gambari R
Int J Hematol; 2009 Oct; 90(3):318-327. PubMed ID: 19777196
[TBL] [Abstract][Full Text] [Related]
9. Erythroid differentiation ability of butyric acid analogues: identification of basal chemical structures of new inducers of foetal haemoglobin.
Bianchi N; Chiarabelli C; Zuccato C; Lampronti I; Borgatti M; Amari G; Delcanale M; Chiavilli F; Prus E; Fibach E; Gambari R
Eur J Pharmacol; 2015 Apr; 752():84-91. PubMed ID: 25701725
[TBL] [Abstract][Full Text] [Related]
10. Spred2 modulates the erythroid differentiation induced by imatinib in chronic myeloid leukemia cells.
Yang Y; Liu X; Xiao F; Xue S; Xu Q; Yin Y; Sun H; Xu J; Wang H; Zhang Q; Wang H; Wang L
PLoS One; 2015; 10(2):e0117573. PubMed ID: 25688862
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative and erythroid differentiation of piperazine and triphenyl derivatives against k-562 human chronic myelogenous leukemia.
Saab AM; Dobmeier M; Koenig B; Fabri E; Finotti A; Borgatti M; Lampronti I; Bernardi F; Efferth T; Gambari R
Anticancer Res; 2013 Aug; 33(8):3027-32. PubMed ID: 23898056
[TBL] [Abstract][Full Text] [Related]
12. Induction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproducts.
Salvador A; Brognara E; Vedaldi D; Castagliuolo I; Brun P; Zuccato C; Lampronti I; Gambari R
J Photochem Photobiol B; 2013 Apr; 121():57-66. PubMed ID: 23518160
[TBL] [Abstract][Full Text] [Related]
13. The DNA-binding drugs mithramycin and chromomycin are powerful inducers of erythroid differentiation of human K562 cells.
Bianchi N; Osti F; Rutigliano C; Corradini FG; Borsetti E; Tomassetti M; Mischiati C; Feriotto G; Gambari R
Br J Haematol; 1999 Feb; 104(2):258-65. PubMed ID: 10050705
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients.
Fibach E; Prus E; Bianchi N; Zuccato C; Breveglieri G; Salvatori F; Finotti A; Lipucci di Paola M; Brognara E; Lampronti I; Borgatti M; Gambari R
Int J Mol Med; 2012 Jun; 29(6):974-82. PubMed ID: 22378234
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the erythroid differentiation effect of flavonoid apigenin on K562 human chronic leukemia cells.
Isoda H; Motojima H; Onaga S; Samet I; Villareal MO; Han J
Chem Biol Interact; 2014 Sep; 220():269-77. PubMed ID: 25058688
[TBL] [Abstract][Full Text] [Related]
16. Changes in DNA methylation of erythroid-specific genes in K562 cells exposed to phenol and hydroquinone.
Li Y; Wu XR; Li XF; Suriguga ; Yu CH; Li YR; Yi ZC
Toxicology; 2013 Oct; 312():108-14. PubMed ID: 23973255
[TBL] [Abstract][Full Text] [Related]
17. Tenofovir disoproxil fumarate induces fetal hemoglobin production in K562 cells and β-YAC transgenic mice: A therapeutic approach for γ-globin induction.
Khan F; Ali H; Musharraf SG
Exp Cell Res; 2020 Sep; 394(2):112168. PubMed ID: 32653411
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis and erythroid differentiation of human chronic myelogenous leukemia K562 cells by low concentrations of lidamycin.
Zhang C; Guo LY; Mu D; Gong JH; Chen J
Oncol Rep; 2019 Jan; 41(1):475-482. PubMed ID: 30542729
[TBL] [Abstract][Full Text] [Related]
19. Novel agent nitidine chloride induces erythroid differentiation and apoptosis in CML cells through c-Myc-miRNAs axis.
Liu N; Li P; Zang S; Liu Q; Ma D; Sun X; Ji C
PLoS One; 2015; 10(2):e0116880. PubMed ID: 25647305
[TBL] [Abstract][Full Text] [Related]
20. Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity.
Honma Y; Okabe-Kado J; Hozumi M; Uehara Y; Mizuno S
Cancer Res; 1989 Jan; 49(2):331-4. PubMed ID: 2910452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
